Search

everythinglearnresearchcommunity

for

Search:↓

It's unclear if cell-based therapies from lipoaspirate devices improve clinical outcomes due to inconsistent data.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Public interest in finasteride's sexual side effects has significantly increased.

Underactive bladder is hard to diagnose and treat, needing more research.

Standardized kits improve the quality and consistency of isolating stem cells from fat tissue.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Combining TUSV with finasteride effectively treats recurrent hemospermia.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Many patients with lower urinary tract symptoms also have undiagnosed erectile dysfunction, which improves with treatment.

Dual therapy with specific medications can help manage male urinary symptoms and reduce side effects.

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Dutasteride effectively treats enlarged prostate with manageable side effects.

A new method using a Foley catheter on a ureteroscope makes difficult urethral catheterization easier and more effective.

Rats had lasting erectile problems after stopping a certain medication.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Evidence-based urology improved treatment and quality of life for conditions like BPH by shifting from surgery to effective medications like finasteride and dutasteride.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Surgery, especially prostatectomy, effectively reduces detrusor overactivity in bladder outlet obstruction patients.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.